[Perspective] Could microbial therapy boost cancer immunotherapy?

Science: Current Issue
Immunotherapies known as checkpoint blockades are rapidly changing standard treatment and outcomes for patients with advanced malignancies, as they lead to long-term disease control in a subset of patients (1). On pages 1084 and 1079 of this issue, Sivan et al. (2) and Vétizou et al. (3), respectively, illustrate an important role for the gut microbiome in modulating the efficacy of this treatment. Authors: Alexandra Snyder, Eric Pamer, Jedd Wolchok
Read More...

Comments

Popular posts from this blog

Yu Founder On Next Flagship and Open Source Model for Upcoming Smartphones

Vivo V3Max Review

Xiaomi Mi 5 in Pictures